0001038074
false
0001038074
2023-11-01
2023-11-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
November 1, 2023
SILICON LABORATORIES INC.
(Exact Name of Registrant as Specified in
Charter)
Delaware |
|
000-29823 |
|
74-2793174 |
(State or Other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
400 West Cesar Chavez, Austin, TX |
|
78701 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including
area code: (512) 416-8500
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.0001 par value |
|
SLAB |
|
The NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth
company ¨
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of
1934. ¨
Item 2.02. Results of Operations and Financial Condition
On November 1, 2023, Silicon Laboratories Inc. (“Silicon
Laboratories”) issued a press release announcing its results of operations for its fiscal quarter ended September 30, 2023.
A copy of the press release is attached as Exhibit 99 to this report.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Use of Non-GAAP Financial Information
From time to time, Silicon Laboratories provides certain non-GAAP financial
measures as additional information relating to its operating results. The non-GAAP financial measurements provided in the press release
furnished herewith do not replace the presentation of Silicon Laboratories’ GAAP financial results. These additional measurements
merely provide supplemental information to assist investors in analyzing Silicon Laboratories’ financial position and results of
operations; however, these measures are not in accordance with, or an alternative to, GAAP and may be different from non-GAAP measures
used by other companies.
Non-GAAP financial measures used by Silicon Laboratories include non-GAAP
gross profit, non-GAAP gross margin, non-GAAP research and development expense and non-GAAP research and development expense as a percentage
of revenue, non-GAAP selling, general and administrative expense and non-GAAP selling, general and administrative as a percentage of revenue,
non-GAAP operating expenses and non-GAAP operating expenses as a percentage of revenue, non-GAAP operating income and non-GAAP operating
income as a percentage of revenue, non-GAAP income before income taxes and equity-method earnings (loss), non-GAAP tax expense, non-GAAP
tax rate, non-GAAP net income, and non-GAAP diluted earnings per share. Silicon Laboratories has chosen to provide this information to
investors because it believes that such supplemental information enables them to perform meaningful comparisons of past, present and future
operating results, and as a means to highlight the results of core ongoing operations.
Non-GAAP financial measures are adjusted by the following items:
· |
Stock compensation expense
– represents charges for employee stock awards issued under Silicon Laboratories’ stock-based
compensation plans. Stock compensation expense is excluded from non-GAAP financial measures because it is a non-cash expense, and
excluding such expense provides meaningful supplemental information regarding core ongoing operations. |
· |
Intangible asset amortization
– primarily represents charges for the amortization of intangibles assets, such as
core and developed technology, customer relationships and trademarks acquired in connection with business combinations. Intangible
asset amortization is excluded from non-GAAP financial measures because it is a non-cash expense, and excluding such expense provides
meaningful supplemental information regarding core ongoing operations. |
· |
Acquisition and disposition related
items – primarily including the following: charges for the fair value write-up associated
with inventory acquired; adjustments to the fair value of acquisition-related contingent consideration; and acquisition-related costs
of a business combination or disposition-related costs of a business divestiture, such as costs for attorneys, investment bankers,
accountants and other third party service providers. Acquisition and disposition related items are excluded from non-GAAP financial
measures because excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
· |
Termination costs, impairments,
and fair value and other adjustments – primarily include costs associated with certain
employee terminations, asset impairments, fair value adjustments resulting from observable price changes and other non-cash adjustments.
Termination costs, impairments, and fair value and other adjustments are excluded from non-GAAP financial measures because excluding
such amounts provides meaningful supplemental information regarding core ongoing operations. |
· |
Equity-method investment adjustments
– primarily include the proportionate share of gains and/or losses from investments
accounted for by the equity method of accounting. Equity-method investment adjustments are excluded from non-GAAP financial measures
because these generally are non-cash, represent non-operating activity during the period of adjustment, relate to activity in entities
outside of the operational control of Silicon Laboratories, and excluding such expense/gain provides meaningful supplemental information
regarding core operations. |
· |
Interest expense adjustments
– represents losses or gains on the extinguishment of convertible debt and losses
or gains on the termination of interest rate swap agreements. Such amounts are excluded from non-GAAP financial measures because
they are non-cash expenses and/or excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
· |
Income tax adjustments
– primarily include the following: the current and deferred income tax effects of the above non-GAAP
adjustments; other indirect impacts of excluding stock-based compensation; and the income tax impact of certain intercompany license
arrangements for technology acquired in business combinations. Income tax adjustments are excluded from non-GAAP financial measures
because excluding such amounts provides meaningful supplemental information regarding core ongoing operations. |
Pursuant to the requirements of Regulation G, we have provided in
the press release furnished with this report a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP
financial measures.
The information in this report, including the exhibit hereto, shall
not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liability of that section. The information contained therein and in the accompanying exhibit shall not be incorporated
by reference into any filing with the U.S. Securities and Exchange Commission made by Silicon Laboratories, whether made before or after
the date hereof, regardless of any general incorporation language in such filing.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SILICON LABORATORIES INC. |
|
|
|
November 1,
2023 |
|
/s/
John C. Hollister |
Date |
|
John C. Hollister |
|
|
Senior Vice President
and |
|
|
Chief Financial Officer |
|
|
(Principal Financial
Officer) |
Exhibit 99
Silicon Labs
Reports Third Quarter 2023 Results
IoT leader delivers
solid results in a challenging market environment
AUSTIN,
Texas – November 1, 2023 – Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless
technology for a more connected world, reported financial results for the third quarter, which ended September 30, 2023.
“The Silicon Labs team executed well in the third quarter, driving
revenue and EPS that exceeded the mid-point of our guidance,” said Matt Johnson, President and Chief Executive Officer at Silicon
Labs. “The current demand environment remains quite weak as we navigate this cyclical inventory correction, and end market visibility
continues to be challenging. That said, we are pleased with our record design win performance in the quarter and continued advancements
in our industry-leading platform. We believe this positions us well for growth and higher earnings power when the market recovers.”
Third Quarter Financial Highlights
| · | Revenue
was $204 million |
| · | Industrial &
Commercial revenue for the quarter was $121 million |
| · | Home &
Life revenue for the quarter was $83 million |
Results on a GAAP basis:
| · | GAAP
gross margin was 58.4% |
| · | GAAP
R&D expenses were $79 million |
| · | GAAP
SG&A expenses were $28 million |
| · | GAAP
operating income as a percentage of revenue was 6% |
| · | GAAP
diluted earnings per share were $0.32 |
Results on a non-GAAP basis, excluding the impact of stock compensation,
amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables
were as follows:
| · | Non-GAAP
gross margin was 58.5% |
| · | Non-GAAP
R&D expenses were $64 million |
| · | Non-GAAP
SG&A expenses were $31 million |
| · | Non-GAAP
operating income as a percentage of revenue was 12% |
| · | Non-GAAP
diluted earnings per share were $0.62 |
Business Highlights
| · | Hosted
its fourth annual Works With Conference in August, which attracted thousands of top IoT developers
and included panels with partners from Amazon, Google, Samsung, and many more. The virtual
event covered a broad range of IoT technologies and trends, including Bluetooth, Wi-Fi, Matter,
Wi-Sun, and Amazon Sidewalk, as well as the latest developments in security and AI/ML. |
| · | Announced
its next-generation Series 3 platform, purpose-built for embedded IoT devices. Series 3
devices will be designed to offer industry-leading compute, wireless performance, scalability,
and energy efficiency with the highest levels of IoT security. Notably, new levels of compute
will bring more than 100x the processing capability of Series 2 and will include integrated
AI/ ML accelerators for edge devices, enabling consolidation of system processing into wireless
SoCs. Silicon Labs also announced the next version of their developer tool suite, Simplicity
Studio, to help developers and device manufacturers streamline and accelerate product designs. |
Business Outlook
The company expects fourth-quarter revenue to be between $70 to $100
million. The company also estimates the following results:
On a GAAP basis:
| · | GAAP
gross margin to be 53% |
| · | GAAP
operating expenses of approximately $123 million |
| · | GAAP
diluted earnings (loss) per share between $(2.39) to $(1.95) |
On a non-GAAP basis, excluding the impact of stock compensation, amortization
of acquired intangible assets, and certain other items as set forth in the reconciliation tables:
| · | Non-GAAP
gross margin to be 53% |
| · | Non-GAAP
operating expenses of approximately $94 million |
| · | Non-GAAP
diluted earnings (loss) per share between $(1.66) to $(1.22) |
Earnings Webcast and Conference Call
Silicon Labs
will host an earnings conference call to discuss the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will
be available on Silicon Labs' website (www.silabs.com) under Investor Relations. In addition, the company will post
an audio recording of the event at investor.silabs.com and make a replay available through December 1, 2023.
About Silicon Labs
Silicon Labs
(NASDAQ: SLAB) is a leader in secure, intelligent wireless technology for a more connected world. Our integrated hardware
and software platform, intuitive development tools, thriving ecosystem, and robust support make us an ideal long-term
partner in building advanced industrial, commercial, home and life applications. We make it easy for developers to
solve complex wireless challenges throughout the product lifecycle and get to market quickly with innovative solutions
that transform industries, grow economies, and improve lives. silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on Silicon
Labs’ current expectations. The words “believe”, “estimate”, “expect”, “intend”,
“anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon
Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions
of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations.
Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following:
the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in
the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia
that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political
unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between
Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan
and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating
results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including
trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures;
product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers
and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks;
difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth;
credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of COVID-19 on
the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average
selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’
products and its networks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims
any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events,
or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the “S”
symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks
of their respective holders.
CONTACT: Thomas Haws, Investor Relations Manager, (512) 416-8500,
investor.relations@silabs.com
Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
| |
Three Months
Ended | | |
Nine Months
Ended | |
| |
September 30,
2023 | | |
October 1,
2022 | | |
September 30,
2023 | | |
October 1,
2022 | |
Revenues | |
$ | 203,760 | | |
$ | 269,817 | | |
$ | 695,413 | | |
$ | 766,781 | |
Cost of revenues | |
| 84,735 | | |
| 104,232 | | |
| 278,753 | | |
| 281,521 | |
Gross profit | |
| 119,025 | | |
| 165,585 | | |
| 416,660 | | |
| 485,260 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Research and development | |
| 79,042 | | |
| 84,624 | | |
| 254,340 | | |
| 245,677 | |
Selling, general and
administrative | |
| 27,766 | | |
| 50,738 | | |
| 113,363 | | |
| 144,398 | |
Operating expenses | |
| 106,808 | | |
| 135,362 | | |
| 367,703 | | |
| 390,075 | |
Operating income | |
| 12,217 | | |
| 30,223 | | |
| 48,957 | | |
| 95,185 | |
Other income (expense): | |
| | | |
| | | |
| | | |
| | |
Interest income and other, net | |
| 2,938 | | |
| 4,672 | | |
| 15,554 | | |
| 9,616 | |
Interest expense | |
| (1,359 | ) | |
| (1,527 | ) | |
| (4,611 | ) | |
| (4,874 | ) |
Income before income taxes | |
| 13,796 | | |
| 33,368 | | |
| 59,900 | | |
| 99,927 | |
Provision for income taxes | |
| 3,388 | | |
| 14,188 | | |
| 23,479 | | |
| 36,871 | |
Equity-method earnings (loss) | |
| (60 | ) | |
| 1,819 | | |
| (1,150 | ) | |
| 2,985 | |
Net income | |
$ | 10,348 | | |
$ | 20,999 | | |
$ | 35,271 | | |
$ | 66,041 | |
| |
| | | |
| | | |
| | | |
| | |
Earnings per share: | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | 0.33 | | |
$ | 0.62 | | |
$ | 1.11 | | |
$ | 1.84 | |
Diluted | |
$ | 0.32 | | |
$ | 0.60 | | |
$ | 1.07 | | |
$ | 1.79 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted-average common shares outstanding: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 31,796 | | |
| 34,079 | | |
| 31,789 | | |
| 35,935 | |
Diluted | |
| 32,078 | | |
| 34,779 | | |
| 32,919 | | |
| 36,968 | |
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout
this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits.
Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.
The non-GAAP financial measurements do not replace
the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management
and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this
information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means
to emphasize the results of core on-going operations.
Unaudited Reconciliation of GAAP to Non-GAAP
Financial Measures
(In thousands, except per share data)
| |
Three
Months Ended September 30,
2023 | |
Non-GAAP Income Statement
Items | |
GAAP Measure | | |
GAAP Percent
of
Revenue | | |
Stock
Compensation
Expense | | |
Intangible
Asset
Amortization | | |
Termination
Costs | | |
Non-GAAP Measure | | |
Non-GAAP Percent
of
Revenue | |
Revenues | |
$ | 203,760 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Gross profit | |
| 119,025 | | |
| 58.4 | % | |
$ | 192 | | |
$ | -- | | |
$ | 18 | | |
$ | 119,235 | | |
| 58.5 | % |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Research and development | |
| 79,042 | | |
| 38.8 | % | |
| 8,598 | | |
| 6,239 | | |
| 269 | | |
| 63,936 | | |
| 31.4 | % |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Selling, general and administrative | |
| 27,766 | | |
| 13.6 | % | |
| (3,000 | ) | |
| 19 | | |
| 8 | | |
| 30,739 | | |
| 15.1 | % |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Operating income | |
| 12,217 | | |
| 6.0 | % | |
| 5,790 | | |
| 6,258 | | |
| 295 | | |
| 24,560 | | |
| 12.1 | % |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
Three
Months Ended September 30,
2023 | |
Non-GAAP Earnings
Per Share | |
GAAP Measure | | |
Stock Compensation
Expense* | | |
Intangible
Asset
Amortization* | | |
Termination
Costs* | | |
Equity-Method Investment
Adjustments* | | |
Income Tax Adjustments | | |
Non- GAAP Measure | |
Net income | |
$ | 10,348 | | |
$ | 5,790 | | |
$ | 6,258 | | |
$ | 295 | | |
$ | 60 | | |
$ | (2,778 | ) | |
$ | 19,973 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Diluted shares outstanding | |
| 32,078 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| 32,078 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Diluted earnings per share | |
$ | 0.32 | | |
| | | |
| | | |
| | | |
| | | |
| | | |
$ | 0.62 | |
* Represents pre-tax amounts
Unaudited Forward-Looking Statements Regarding
Business Outlook
(In millions, except per share data)
| |
Three
Months Ending December 30,
2023 | |
Business Outlook | |
| GAAP Measure | | |
| Non-GAAP Adjustments** | | |
| Non-GAAP Measure | |
Gross margin | |
| 53 | % | |
| 0 | % | |
| 53 | % |
| |
| | | |
| | | |
| | |
Operating expenses | |
$ | 123 | | |
$ | (29 | ) | |
$ | 94 | |
| |
| | | |
| | | |
| | |
Diluted earnings (loss) per share - low | |
$ | (2.39 | ) | |
$ | 0.73 | | |
$ | (1.66 | ) |
| |
| | | |
| | | |
| | |
Diluted earnings (loss) per share - high | |
$ | (1.95 | ) | |
$ | 0.73 | | |
$ | (1.22 | ) |
** Non-GAAP adjustments include the following estimates: stock
compensation expense of $16.5 million, intangible asset amortization of $6.2 million, termination costs of $6.5 million, and the associated
tax impact from the aforementioned items.
Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
| |
September 30, 2023 | | |
December 31, 2022 | |
Assets | |
| | | |
| | |
Current assets: | |
| | | |
| | |
Cash
and cash equivalents | |
$ | 159,928 | | |
$ | 499,915 | |
Short-term
investments | |
| 257,157 | | |
| 692,024 | |
Accounts
receivable, net | |
| 102,142 | | |
| 71,437 | |
Inventories | |
| 167,581 | | |
| 100,417 | |
Prepaid
expenses and other current assets | |
| 86,727 | | |
| 97,570 | |
Total current
assets | |
| 773,535 | | |
| 1,461,363 | |
Property and
equipment, net | |
| 150,839 | | |
| 152,016 | |
Goodwill | |
| 376,389 | | |
| 376,389 | |
Other intangible
assets, net | |
| 65,744 | | |
| 84,907 | |
Other
assets, net | |
| 108,555 | | |
| 94,753 | |
Total
assets | |
$ | 1,475,062 | | |
$ | 2,169,428 | |
| |
| | | |
| | |
Liabilities
and Stockholders’ Equity | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts
payable | |
$ | 48,086 | | |
$ | 89,860 | |
Revolving
line of credit | |
| 45,000 | | |
| -- | |
Deferred
revenue and returns liability | |
| 10,066 | | |
| 6,780 | |
Other
current liabilities | |
| 61,991 | | |
| 89,136 | |
Total current
liabilities | |
| 165,143 | | |
| 185,776 | |
Convertible
debt, net | |
| -- | | |
| 529,573 | |
Other
non-current liabilities | |
| 49,997 | | |
| 49,071 | |
Total liabilities | |
| 215,140 | | |
| 764,420 | |
Commitments
and contingencies | |
| | | |
| | |
Stockholders’
equity: | |
| | | |
| | |
Preferred stock – $0.0001
par value; 10,000 shares authorized; no shares issued | |
| -- | | |
| -- | |
Common stock –
$0.0001 par value; 250,000 shares authorized; 31,779 and 31,994 shares issued and outstanding at September 30, 2023 and December 31,
2022, respectively | |
| 3 | | |
| 3 | |
Retained
earnings | |
| 1,262,518 | | |
| 1,415,693 | |
Accumulated
other comprehensive loss | |
| (2,599 | ) | |
| (10,688 | ) |
Total
stockholders’ equity | |
| 1,259,922 | | |
| 1,405,008 | |
Total
liabilities and stockholders’ equity | |
$ | 1,475,062 | | |
$ | 2,169,428 | |
Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
| |
Nine Months
Ended | |
| |
September 30, 2023 | | |
October 1, 2022 | |
Operating Activities | |
| | | |
| | |
Net income | |
$ | 35,271 | | |
$ | 66,041 | |
Adjustments
to reconcile net income to net cash provided by (used in) operating activities of continuing operations: | |
| | | |
| | |
Depreciation of property and equipment | |
| 18,992 | | |
| 16,514 | |
Amortization of other intangible assets | |
| 19,162 | | |
| 27,328 | |
Amortization of debt issuance costs | |
| 960 | | |
| 1,492 | |
Loss on extinguishment of convertible debt | |
| -- | | |
| 3 | |
Stock-based compensation expense | |
| 37,167 | | |
| 43,213 | |
Equity-method (earnings) loss | |
| 1,150 | | |
| (2,985 | ) |
Deferred income taxes | |
| (5,881 | ) | |
| (13,126 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| (30,706 | ) | |
| 21,641 | |
Inventories | |
| (66,971 | ) | |
| (39,100 | ) |
Prepaid expenses and other
assets | |
| 8,085 | | |
| (28,404 | ) |
Accounts payable | |
| (37,039 | ) | |
| 26,694 | |
Other current liabilities
and income taxes | |
| (39,155 | ) | |
| 17,962 | |
Deferred revenue and returns
liability | |
| 3,286 | | |
| (2,144 | ) |
Other
non-current liabilities | |
| 6,794 | | |
| (7,713 | ) |
Net cash provided by (used in) operating activities of continuing
operations | |
| (48,885 | ) | |
| 127,416 | |
| |
| | | |
| | |
Investing Activities | |
| | | |
| | |
Purchases of marketable securities | |
| (91,493 | ) | |
| (579,507 | ) |
Sales of marketable securities | |
| 365,073 | | |
| 42,952 | |
Maturities of marketable securities | |
| 171,766 | | |
| 597,399 | |
Purchases of property and equipment | |
| (18,533 | ) | |
| (20,057 | ) |
Purchases of other assets | |
| (395 | ) | |
| -- | |
Net cash provided by investing activities of continuing operations | |
| 426,418 | | |
| 40,787 | |
| |
| | | |
| | |
Financing Activities | |
| | | |
| | |
Proceeds from revolving line of credit | |
| 80,000 | | |
| -- | |
Payments on debt | |
| (571,157 | ) | |
| (21 | ) |
Repurchases of common stock | |
| (217,137 | ) | |
| (681,695 | ) |
Payment of taxes withheld for vested stock awards | |
| (17,239 | ) | |
| (14,732 | ) |
Proceeds from the issuance of common
stock | |
| 8,013 | | |
| 6,366 | |
Net cash used in financing activities of continuing operations | |
| (717,520 | ) | |
| (690,082 | ) |
| |
| | | |
| | |
Discontinued Operations | |
| | | |
| | |
Operating activities | |
| -- | | |
| (69,467 | ) |
Net cash used in discontinued operations | |
| -- | | |
| (69,467 | ) |
| |
| | | |
| | |
Decrease in cash and cash equivalents | |
| (339,987 | ) | |
| (591,346 | ) |
Cash and cash equivalents at beginning
of period | |
| 499,915 | | |
| 1,074,623 | |
Cash and cash equivalents at end of
period | |
$ | 159,928 | | |
$ | 483,277 | |
v3.23.3
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Silicon Labs (NASDAQ:SLAB)
Historical Stock Chart
From Apr 2024 to May 2024
Silicon Labs (NASDAQ:SLAB)
Historical Stock Chart
From May 2023 to May 2024